Literature DB >> 6820177

[Continuous partial epilepsy: syndrome and disease].

J Bancaud, A Bonis, S Trottier, J Talairach, O Dulac.   

Abstract

Twenty three patients are described with a Kojewnikow syndrome in order to identify possible etiological factors. According to their history, clinical and E.E.G. features, patients could be classified into two groups; 1) Eleven patients corresponded to the classical description of the Kojewnikow syndrome: variable age at onset of the disease, rare somatomotor seizures, delay of onset of myoclonic jerks often of long duration, myoclonus limited to a small region, normal neurological examination, stable hemiplegia, normal results of psychometric tests, localised E.E.G. alterations. In most of these patients the etiology of the disorder was known, and the symptoms could be related to a localised lesion of the central cortex; 2) the second group (11 patients) presented with completely different characteristics: early onset of fits (age: 2 to 10 years), presence of other seizure types, short delay of onset of myoclonic jerks, high frequency of seizures, localization of myoclonus over large parts of the body, progressive evolution of a motor syndrome, associated neurological signs and disorders of sleep and behavior, progressive mental deterioration, characteristic E.E.G. pattern with long subclinical paroxysms of slow spikes (sharp waves) with variable localization, diffuse cerebral lesions of unknown etiology were found. Only one patient could not be allocated to either group. Several circumstantial data suggest that patients of the second group may suffer from a slow virus infection. Should this hypothesis be confirmed, a reconsideration of the Kojewnikow syndrome from the etiological standpoint would be of great theoretical and practical interest.

Entities:  

Mesh:

Year:  1982        PMID: 6820177

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  10 in total

Review 1.  [Recent insights into Rasmussen encephalitis].

Authors:  C G Bien; C E Elger
Journal:  Nervenarzt       Date:  2005-12       Impact factor: 1.214

2.  Neurophysiological follow-up in a case of chronic progressive epilepsia partialis continua of childhood.

Authors:  T Perniola; E Sforza; M Rodriguez; L Margari
Journal:  Ital J Neurol Sci       Date:  1989-06

3.  "Epilepsia partialis continua" due to multifocal encephalitis: favourable outcome after immunoglobulin treatment.

Authors:  F Barontini; S Maurri; A Amantini
Journal:  Ital J Neurol Sci       Date:  1994-04

4.  Chronic localised encephalitis (Rasmussen's) in an adult with epilepsia partialis continua.

Authors:  F Gray; M Serdaru; H Baron; C Daumas-Duport; P Loron; B Sauron; J Poirier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

5.  Status epilepticus in acute ischemic stroke.

Authors:  T Sacquegna; P de Carolis; M Crisci; S Laudadio; A Baldrati; A S Gabellini; G Procaccianti
Journal:  Ital J Neurol Sci       Date:  1995-10

6.  Simple partial status epilepticus: causes, treatment, and outcome in 47 patients.

Authors:  F B Scholtes; W O Renier; H Meinardi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

7.  Reversible operculum syndrome caused by progressive epilepsia partialis continua in a child with left hemimegalencephaly.

Authors:  L Fusco; F Vigevano
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-06       Impact factor: 10.154

8.  Early-onset progressive encephalopathy with migrant, continuous myoclonus.

Authors:  R Gaggero; M P Baglietto; R Curia; M De Negri
Journal:  Childs Nerv Syst       Date:  1996-05       Impact factor: 1.475

9.  Menkes disease presenting with epilepsia partialis continua.

Authors:  Tamer Rizk; Adel Mahmoud; Tahani Jamali; Salah Al-Mubarak
Journal:  Case Rep Neurol Med       Date:  2014-11-23

10.  Continuous Visual Focal Status Epilepticus as the Primary Presentation of NMDA-R and GAD65-R Autoimmune Epilepsy.

Authors:  Elma M Paredes-Aragón; Héctor E Valdéz-Ruvalcaba; Andrea Santos-Peyret; Marcela Cisneros-Otero; Raúl Medina-Rioja; Sandra Orozco-Suárez; Miriam M Hernandez; Michele D L Breda-Yepes; Verónica Rivas-Alonso; José J Flores-Rivera; Iris E Martínez-Juárez
Journal:  Front Neurol       Date:  2020-11-26       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.